• OPEN AN ACCOUNT
Indian Indices
Sensex
72,369.85 776.61
( 1.08%)
Global Indices
Nasdaq
51,245.91 45.04
(0.09%)
Dow Jones
7,786.38 -36.39
(-0.47%)
Hang Seng
69,343.08 -692.63
(-0.99%)
Nikkei 225
10,441.54 -16.96
(-0.16%)
Forex
USD-INR
96.67 0.30
(0.31%)
EUR-INR
108.31 -0.02
(-0.02%)
GBP-INR
127.86 0.18
(0.14%)
JPY-INR
0.61 0.00
(0.24%)

EQUITY - MARKET SCREENER

Sun Retail Ltd
Industry :  Trading
BSE Code
ISIN Demat
Book Value()
542025
INE206Z01020
1.0613335
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
0
6.83
EPS(TTM)
Face Value()
Div & Yield %
0
1
0
 

Glaxosmithkline Pharmaceuticals consolidated net profit rises 5.70% in the March 2026 quarter
May 13,2026
Net profit of Glaxosmithkline Pharmaceuticals rose 5.70% to Rs 277.86 crore in the quarter ended March 2026 as against Rs 262.87 crore during the previous quarter ended March 2025. Sales rose 2.15% to Rs 995.30 crore in the quarter ended March 2026 as against Rs 974.37 crore during the previous quarter ended March 2025.

For the full year,net profit rose 11.69% to Rs 1035.98 crore in the year ended March 2026 as against Rs 927.58 crore during the previous year ended March 2025. Sales rose 1.93% to Rs 3821.67 crore in the year ended March 2026 as against Rs 3749.21 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales995.30974.37 2 3821.673749.21 2
OPM %35.2634.20 -34.2631.40 -
PBDT386.27373.29 3 1451.831321.98 10
PBT373.10358.57 4 1385.391255.19 10
NP277.86262.87 6 1035.98927.58 12